perfosfamide has been researched along with Glial Cell Tumors in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brem, H; Buahin, KG; Colvin, OM; Domb, A; Epstein, JI; Judy, KD; Olivi, A | 1 |
| Archer, GE; Bigner, DD; Colvin, OM; Friedman, HS; Fuchs, HE; McLendon, RE; Schuster, JM | 1 |
| Baraban, J; Brem, H; Burger, PC; Li, KW; Piantadosi, S; Ratan, R; Sipos, EP; Witham, TF | 1 |
3 other study(ies) available for perfosfamide and Glial Cell Tumors
| Article | Year |
|---|---|
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cyclophosphamide; Decanoic Acids; Delayed-Action Preparations; Dicarboxylic Acids; Drug Implants; Erucic Acids; Glioma; Male; Neoplasm Transplantation; Polymers; Rats; Rats, Inbred F344; Survival Rate; Tumor Cells, Cultured | 1995 |
Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
Topics: Animals; Body Weight; Brain Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Glioma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Mice; Mice, Nude; Rats; Rats, Nude; Transplantation, Heterologous | 1993 |
L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Brain; Brain Neoplasms; Buthionine Sulfoximine; Cyclophosphamide; Drug Combinations; Drug Implants; Drug Synergism; Glioma; Glutathione; Injections, Intraperitoneal; Liver; Male; Rats; Rats, Inbred F344; Reference Values; Survival Analysis | 2001 |